Rhythm Pharmaceuticals files prospectus for resale of 3.1M shares by selling stockholders

RHYTHM PHARMACEUTICALS, INC.

Registration covers up to 3,124,995 common shares held by certain stockholders to satisfy registration rights.
Shares issuable upon conversion of Series A Convertible Preferred Stock sold on April 15, 2024 for $150M.
Legal opinion of Latham & Watkins filed as Exhibit 5.1 and incorporated into S-3ASR registration statement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.